Since 2018, China Focus has been held in San Francisco, Philadelphia, Boston andVienna, attracted more than 500 companies and 750 executives from world wide. It has become the most important brand activity for cross-border collaboration between China and around the world.
- NMPA (previously CFDA) regulatory reforms and new opportunities for biotech & pharmaceutical companies
- New IPO opportunities and their impact on the valuation of biotech companies: HKEX and STAR Market
- European biotech space: how is it unique?
- Current and future hot spots in modality and therapeutic area – where can China and Europe join forces?
- China showcase: featuring leading Chinese companies
– Panel Discussion
– China Showcase
– 1-on-1 Meeting
– Pitch and Match